Proto Script Pharmaceutical Corp.
PSCR · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $1,867 | $1,966 | $9,045 | $88,278 |
| - Cash | $0 | $0 | $56 | $4 |
| + Debt | $373 | $238 | $69 | $51 |
| Enterprise Value | $2,240 | $2,203 | $9,058 | $88,325 |
| Revenue | $252 | $114 | $138 | $100 |
| % Growth | 120.3% | -17.3% | 37.8% | – |
| Gross Profit | $214 | $30 | $107 | $1 |
| % Margin | 84.8% | 26.3% | 77.6% | 0.6% |
| EBITDA | -$164 | -$211 | -$92 | -$378 |
| % Margin | -64.9% | -184.8% | -66.7% | -376.7% |
| Net Income | -$284 | -$333 | -$506 | -$7,264 |
| % Margin | -112.6% | -290.8% | -365.8% | -7,238.9% |
| EPS Diluted | -0.006 | -0.007 | -0.003 | -0.077 |
| % Growth | 14.7% | -100% | 95.6% | – |
| Operating Cash Flow | -$24 | -$105 | -$215 | $41 |
| Capital Expenditures | -$1 | -$12 | -$9 | -$12 |
| Free Cash Flow | -$25 | -$116 | -$224 | $29 |